Over 90 percent of pancreatic cancers harbor a somatic KRAS mutation; furthermore, these mutations appear to occur very early in pancreatic carcinogenesis, as indicated by their presence in noninvasive precursors [60]. This evidence concerns the gene KRAS and pancreatic neoplasm.